RankAlpha logo
Back to Rankings

TBPH

Theravance BiopharmaC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
Current thesis
The post-earnings bull case is that Q1 results reinforced the non-pipeline value floor: quarter-end cash was about $395 million with no debt, Q1 net loss narrowed materially year over year to $4.9 million from $13.6 million, YUPELRI trends stayed positive, and management reiterated confidence in the 2026 TRELEGY milestone path [#8-K-2026-05-07] [#10-Q-2026-05-07].
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +6.0.
What can break
Management's $60-$70 million annualized cash-flow goal depends on delivering the planned restructuring and sustaining lower operating expenses into Q3 2026 and beyond [#8-K-2026-05-07].
Momentum
36
Value
54
Sentiment
58
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $17.00 · Bull $22.00 · Bear $13.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-08 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $21.00
Why
Momentum36 · Δ7d -9.8
Value54 · Δ7d +0.1
Sentiment58 · Δ7d +6.0
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Sentiment · See AI snapshot
Momentum
36
34% active weight
Current posture
7d trendSoftening
Δ7d
-9.8
Δ21d
-16.3
Value
54
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
58
33% active weight
Current posture
7d trendImproving
Δ7d
+6.0
Δ21d
+11.9
Why this grade

Composite grade C. Momentum 36.0 / Value 53.8 / Sentiment 58.4

Fundamentals (TTM)
As of 2026-06-01
Market Cap
$821.76M
Beta
0.15
Shares Out
50.67M
P/E (TTM)
32.7
P/S (TTM)
11.62
P/FCF (TTM)
3.83
Rev YoY
+18.5%
EPS YoY
+126.9%
Gross Margin
-
Op Margin
-40.9%
Net Debt
-$58.02M
Current Ratio
9.48
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology